Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Spero Therapeutics Inc (NASDAQ:SPRO)

12.10
Delayed Data
As of Jan 17
 -0.15 / -1.22%
Today’s Change
9.84
Today|||52-Week Range
15.40
+2.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

--

--
Revenue and IncomeNet Revenues0.00335.0K----
 
 
Depreciation And Amortization11.0K279.0K----
 
 
 
 
Operating ExpensesGross Income-11.0K------
 
 
General Expenses13.3M33.3M----
 
 
 
Research And Development11.1M26.3M----
 
 
 
Total Operating Expenses13.3M33.6M----
 
 
 
 
Non-Operating ExpensesOperating Income-13.3M-33.2M----
 
 
 
Extraordinary Credit174.0K580.0K----
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.2M-32.6M----
 
 
 
Minority Interest-3.0M-7.2M----
 
 
 
Preferred Dividend-3.3M-4.4M----
 
 
 
Net Income-10.2M-25.5M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.7M14.7M----
 
 
 
Shares To Calculate EPS Diluted14.7M14.7M----
 
 
 
 
Earnings Per ShareEPS-$0.91-$2.03----
 
 
 
EPS Diluted-$0.91-$2.03----